黄芪注射液对冠状动脉瘤样扩张型冠心病心绞痛的治疗作用

Effect of Huangqi Injection in Treating Angina Pectoris Caused by Coronary Artery Ectasia

【目的】探讨黄芪注射液对冠状动脉瘤样扩张型冠心病心绞痛的治疗作用。【方法】对 12例冠状动脉瘤样扩张型冠心病心绞痛患者 ,先给予阿斯匹林和恬尔心治疗 1周 ,之后在此基础上给予黄芪注射液治疗 1周 ,观察治疗前后的临床症状和心电图变化的情况并作比较。【结果】经阿斯匹林和恬尔心治疗 7d后患者的临床症状和心电图均有好转 (与治疗前比较 ,P <0 0 5 ) ;在此基础上加用黄芪注射液治疗 7d后 ,患者的临床症状和心电图改善非常显著 (与单纯西药治疗组比较 ,P <0 0 1)。【结论】黄芪注射液能改善冠状动脉瘤样扩张型冠心病心绞痛患者的临床症状 ,与西药阿斯匹林和恬尔心有协同作用。

To explore the effects of Huangqi injection in treating angina pectoris(AP) caused by coronary artery ectasia.Twelve cases of AP caused by coronary artery ectasia received a seven day treatment of aspirin and dilthiazem(Regimen 1)and then were treated with Huangqi injection additionally(Regimen 2)for another seven days.The frequency of attack and duration of AP and electrocardiogram(ECG) were examined before and after treatment.The frequency of attack and duration of AP and ECG were decreased after Regimen 1(P<0 05) and decreased more obviously after Regimen 2.The total effective rate of ECG was 25 00% and 41 67% respectively after Regimen 1 and Regimen 2(P<0 01).[Conclusion] Huangqi injection is effective in improving the clinical symptoms of Huangqi injection.